Templates by BIGtheme NET
Healthcare-cropped

HC Stocks to Path! GW Pharmaceuticals PLC (GWPH), Sophiris Bio Inc (NASDAQ:SPHS)

Shares of GW Pharmaceuticals PLC (NASDAQ:GWPH) ended Monday session in green amid volatile trading. The shares closed up +0.91 points or 0.69% at $132.08 with 375,170 shares getting traded. Post opening the session at $131.50, the shares hit an intraday low of $130.07 and an intraday high of $133.02 and the price vacillated in this range throughout the day. The company has a market cap of $3.36 billion and the numbers of outstanding shares have been calculated to be 263.00 million shares.

GW Pharmaceuticals PLC (GWPH) announced positive results of the second randomized, double-blind, placebo-controlled Phase 3 clinical trial of its investigational medicine Epidiolex® (cannabidiol or CBD) for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS), a rare and severe form of childhood-onset epilepsy. In this trial, Epidiolex, when added to the patient’s current treatment, achieved the primary endpoint for both dose levels with high statistical significance. During the treatment period, patients taking Epidiolex 20mg/kg/day achieved a median reduction in monthly drop seizures of 42 percent compared with a reduction of 17 percent in patients taking placebo (p=0.0047), and patients taking Epidiolex 10mg/kg/day achieved a median reduction in monthly drop seizures of 37 percent compared with a reduction of 17 percent in patients taking placebo (p=0.0016).

Shares of Sophiris Bio Inc (NASDAQ:SPHS) ended Monday session in green amid volatile trading. The shares closed up +0.02 points or 0.70% at $2.86. Post opening the session at $2.82, the shares hit an intraday low of $2.78 and an intraday high of $2.94 and the price vacillated in this range throughout the day. The company has a market cap of $82.70 million and the numbers of outstanding shares have been calculated to be 29.12 million shares.

Sophiris Bio Inc (SPHS) announced that Randall E. Woods, president and chief executive officer, will present a corporate overview at the 2016 BIO Investor Forum. The presentation is scheduled for Tuesday, October 18, 2016 at 10:30 a.m. PDT in San Francisco.

The presentation will be webcast live and can be accessed through the Investor Relations page at www.sophiris.com. A replay of the presentation will be available on the Company’s website for 90 days.

 

 

 

About James Smith

James Smith is one of the best author of health care. His articles have appeared in a number of health care sites before and now he is writing on health care for us on regular basis.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

ăn dặm kiểu NhậtResponsive WordPress Themenhà cấp 4 nông thônthời trang trẻ emgiày cao gótshop giày nữdownload wordpress pluginsmẫu biệt thự đẹpepichouseáo sơ mi nữhouse beautiful